STJ: SJM - Five Year Data from the FAME Trial Further Confirms the Sustained, Long Term Benefit of FFR-Guided PCI over Angiography-Guided Intervention

New alert via PocketInfo for STJ:

SJM - Five Year Data from the FAME Trial Further Confirms the Sustained, Long Term Benefit of FFR-Guided PCI over Angiography-Guided Intervention

Press Releases: http://investors.sjm.com/phoenix.zhtml?c=73836&p=irol-news&nyo=0
SEC Filings: http://investors.sjm.com/phoenix.zhtml?c=73836&p=irol-sec
Stock News Alerts by Pocket Info - the app
Our free iPhone and iPad app lets you choose just the tickers you care about from over 2000 US companies and get alerts to your screen
https://itunes.apple.com/sg/app/stock-news-alerts/id708293183?mt=8